Literature DB >> 15318963

Ototoxicity after use of neomycin eardrops is unrelated to A1555G point mutation in mitochondrial DNA.

Tatsuya Yamasoba1, Katsunori Tsukuda.   

Abstract

Ear drops containing neomycin only rarely cause ototoxicity. The authors report on three patients with a tympanic membrane perforation who developed severe ototoxicity after use of eardrops containing 0.35 per cent neomycin. Mitochondrial DNA analysis revealed that there was no A1555G point mutation in these patients. This finding indicates that application of low concentration neomycin to the middle ear can cause severe inner ear damage even in humans who are not hyper-susceptible to aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15318963     DOI: 10.1258/0022215041615245

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

Review 1.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.

Authors:  John Henry McDermott; Joshua Wolf; Keito Hoshitsuki; Rachel Huddart; Kelly E Caudle; Michelle Whirl-Carrillo; Peter S Steyger; Richard J H Smith; Neal Cody; Cristina Rodriguez-Antona; Teri E Klein; William G Newman
Journal:  Clin Pharmacol Ther       Date:  2021-06-20       Impact factor: 6.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.